Exane Derivatives’s The Aaron's Company Inc Class A AAN.A Stock Holding History

Exane Derivatives’s Portfolio AAN.A Stock Details AAN.A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,118	Closed	-$63.3K	–	888
2020 Q3	$63.3K	Hold	1,118	–	–	0.02%	356
2020 Q2	$50.8K	Sell	1,118 -3,169	-74%	-$144K	0.01%	351
2020 Q1	$97.7K	Sell	4,287 -3,173	-43%	-$72.3K	0.03%	282
2019 Q4	$445K	Buy	7,460 +7,443	+43,782%	+$444K	0.08%	180
2019 Q3	$1.09K	Hold	17	–	–	﹤0.01%	535
2019 Q2	$1.04K	Buy	+17	New	+$1.04K	﹤0.01%	558
2019 Q1	–	Sell	-10,295	Closed	-$433K	–	738
2018 Q4	$433K	Buy	+10,295	New	+$433K	0.08%	189

Other funds holding AAN.A

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

GAM

Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return

Exane Derivatives's AAN.A Position: Q4 2020 in Review

Exane Derivatives sold out of The Aaron's Company Inc Class A (AAN.A) in Q4 2020, closing a stake of 1,118 shares — an estimated $63.3K sold.

Exane Derivatives first reported a position in AAN.A in Q4 2018 and held it in 7 quarters. The position peaked at $445K in Q4 2019. 2 funds tracked by Wall St. Rank hold AAN.A as of Q4 2020.

Exane Derivatives reported no remaining The Aaron's Company Inc Class A position as of Q4 2020 after selling out during the quarter.
Exane Derivatives sold 1,118 The Aaron's Company Inc Class A shares in Q4 2020, an estimated $63.3K.
Exane Derivatives first reported a position in The Aaron's Company Inc Class A in Q4 2018 and held it in 7 quarters.
Exane Derivatives's The Aaron's Company Inc Class A position peaked at $445K in Q4 2019.
2 funds tracked by Wall St. Rank held The Aaron's Company Inc Class A as of Q4 2020.

Based on Exane Derivatives's 13F filing for Q4 2020, filed 27 Jan 2021.